Literature DB >> 33795662

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.

Xiuyuan Ou1, Yan Liu1, Xiaobo Lei1, Pei Li1, Dan Mi1, Lili Ren1, Li Guo1, Ruixuan Guo1, Ting Chen1, Jiaxin Hu1, Zichun Xiang1, Zhixia Mu1, Xing Chen2, Jieyong Chen3, Keping Hu2, Qi Jin4, Jianwei Wang5, Zhaohui Qian6.   

Abstract

Entities:  

Year:  2021        PMID: 33795662      PMCID: PMC8016153          DOI: 10.1038/s41467-021-22614-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


× No keyword cloud information.
Correction to: Nature Communications 10.1038/s41467-020-15562-9, published online 27 March 2020. The original version of the Supplementary Information associated with this Article contained inadvertent errors in Supplementary Fig. 2, in which the image showing results for experiments with TMPRSS4 and SARS-CoV S was duplicated for experiments with TMPRSS4 and SARS-CoV-2 S and the image showing results for experiments with TMPRSS11A and SARS-CoV S was duplicated for experiments with TMPRSS11A and SARS-CoV-2 S. The HTML has been updated to include a corrected version of the Supplementary Information. Supplementary information
  8 in total

1.  Nanokit coupled electrospray ionization mass spectrometry for analysis of angiotensin converting enzyme 2 activity in single living cell.

Authors:  Xinqi Chang; Nina Wang; Depeng Jiang; Hong-Yuan Chen; Dechen Jiang
Journal:  Chin Chem Lett       Date:  2022-05-16       Impact factor: 8.455

Review 2.  Two-Pore Channels Regulate Inter-Organellar Ca2+ Homeostasis in Immune Cells.

Authors:  Philip Steiner; Elisabeth Arlt; Ingrid Boekhoff; Thomas Gudermann; Susanna Zierler
Journal:  Cells       Date:  2022-04-26       Impact factor: 7.666

3.  Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.

Authors:  Chen Huang; Yu Jiang; Jie Yan
Journal:  J Med Virol       Date:  2021-05-19       Impact factor: 20.693

Review 4.  Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?

Authors:  Thomas Abrehart; Randy Suryadinata; Conor McCafferty; Jonathan Jacobson; Vera Ignjatovic; Phil Robinson; Nigel W Crawford; Paul Monagle; Kanta Subbarao; Catherine Satzke; Danielle Wurzel
Journal:  Paediatr Respir Rev       Date:  2022-02-08       Impact factor: 2.726

5.  Theoretical Investigation of the Coronavirus SARS-CoV-2 (COVID-19) Infection Mechanism and Selectivity.

Authors:  Iga Biskupek; Adam Sieradzan; Cezary Czaplewski; Adam Liwo; Adam Lesner; Artur Giełdoń
Journal:  Molecules       Date:  2022-03-24       Impact factor: 4.411

6.  The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants.

Authors:  Cinzia Peronace; Rossana Tallerico; Manuela Colosimo; Marco De Fazio; Federica Pasceri; Ilenia Talotta; Giuseppina Panduri; Letizia Pintomalli; Rosaria Oteri; Valeria Calantoni; Maria Teresa Fiorillo; Maria Cristina Caroleo; Rosita Curcio; Vincenza Dolce; Erika Cione; Pasquale Minchella
Journal:  Biomedicines       Date:  2022-07-30

7.  Immunomolecular assay based on selective virion capture by spike antibody and viral nucleic acid amplification for detecting intact SARS-CoV-2 particles.

Authors:  Xiaoli Wu; Junye Liu; Hongpeng Zhang; Hua Zhou; Wen Wang; Yuanyan Ma; Shimei Shen; Xuefei Cai; Ailong Huang; Deqiang Wang
Journal:  J Nanobiotechnology       Date:  2022-09-05       Impact factor: 9.429

8.  Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy.

Authors:  Saurabh Dahiya; Tim Luetkens; Forat Lutfi; Stephanie Avila; Thierry Iraguha; Philip Margiotta; Kim G Hankey; Patricia Lesho; Jennie Y Law; Seung T Lee; John Baddley; Mehmet Kocoglu; Jean A Yared; Nancy M Hardy; Aaron P Rapoport; Djordje Atanackovic
Journal:  Blood Adv       Date:  2022-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.